Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

BACKGROUND: Pirfenidone is an antifibrotic compound able to slow down disease progression in patients with idiopathic pulmonary fibrosis (IPF). OBJECTIVE: To investigate the safety and efficacy of pirfenidone in patients with IPF in a real-life setting. METHODS: This was a multicenter, retrospective...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Front Med (Lausanne)
मुख्य लेखकों: Tzouvelekis, Argyrios, Karampitsakos, Theodoros, Ntolios, Paschalis, Tzilas, Vasilios, Bouros, Evangelos, Markozannes, Evangelos, Malliou, Ioanna, Anagnostopoulos, Aris, Granitsas, Andreas, Steiropoulos, Paschalis, Dimakou, Katerina, Chrysikos, Serafeim, Koulouris, Nikolaos, Bouros, Demosthenes
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Frontiers Media S.A. 2017
विषय:
Medicine
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5712559/
https://ncbi.nlm.nih.gov/pubmed/29238708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2017.00213
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन